601636:SSEZhuzhou Kibing Group Co., Ltd. Class A Analysis
Data as of 2026-09-08 - not real-time
CN¥5.79
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Zhuzhou Kibing Group Co.,Ltd trades at ¥5.79, with its short-term moving averages sitting below the longer-term ones — a bearish trend structure. Over a rolling month the price has gained 4.9%. Momentum indicators put RSI at 44.3 (neutral) with MACD reading bullish. Watch ¥5.48 as support and ¥6.39 as the nearer resistance level.
Valuation screens as undervalued, on a P/E of 16.3 with no clean sector comparison available. Sell-side targets cluster 23.1% above the current quote. Revenue is contracting at 6.8% on a -2.8% profit margin. The 1.86% dividend yield looks covered by current payout levels.
Risk scores 5 out of 10, which is moderate for this asset class. With 30-day volatility of 37.6%, a beta of 0.68 and a maximum drawdown of 47.0%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 2 out of 10.
Valuation screens as undervalued, on a P/E of 16.3 with no clean sector comparison available. Sell-side targets cluster 23.1% above the current quote. Revenue is contracting at 6.8% on a -2.8% profit margin. The 1.86% dividend yield looks covered by current payout levels.
Risk scores 5 out of 10, which is moderate for this asset class. With 30-day volatility of 37.6%, a beta of 0.68 and a maximum drawdown of 47.0%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 2 out of 10.
Top Market Events
Yahoo Finance1monZhuzhou Kibing Group Co.Investing21dZhuzhou Kibing Group Co LtdEBITDA Multiple, Enterprise Value / EBITDA, or EV / EBITDA measures the dollars...Investing21dZhuzhou Kibing Group Co LtdClick the link below to download a spreadsheet with an example Revenue...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 3/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 6.51
- MACD momentum is positive
Medium Term
1–3 yearsNeutral
Model confidence: 2/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 6.51
- Analyst targets imply +23.1% versus the current price
Long Term
> 3 yearsNeutral
Model confidence: 2/10
Key Factors
- Negative profit margin of -2.8%
- Analyst targets imply +23.1% versus the current price
- Negative return on equity of -3.1%
Key Metrics & Analysis
Financial Health
Revenue Growth-6.80%
Profit Margin-2.82%
P/E Ratio16.3
ROE-3.10%
ROA-0.29%
Debt/Equity76.23
P/B Ratio1.2
Op. Cash FlowCN¥1.6B
Free Cash FlowCN¥2.9B
Technical Analysis
TrendBearish
RSI44.3
SupportCN¥5.48
ResistanceCN¥6.39
MA 20CN¥5.91
MA 50CN¥6.28
MA 200CN¥6.51
MACDBullish
VolumeStable
Fear & Greed Index94.11
Valuation
Fair ValueCN¥9.72
Target PriceCN¥7.13
Upside/Downside23.10%
GradeUndervalued
TypeValue
Dividend Yield1.86%
Risk Assessment
Beta0.68
Volatility37.56%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskHigh
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.